Healthcare
Live Price
Offline$260.00
+1.75% today
Window Change
+3.97%
Window
Jun 23, 2025 → May 14, 2026
Coverage: 226 bars · Jun 23, 2025 → May 14, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bio-Rad Laboratories, Inc. (BIO-B) is a Healthcare stock with a market cap of $7.03B. The stock last traded around $260.00 and up 4.0% across the available one-year price window (Jun 23, 2025 → May 14, 2026). Baseline metrics include revenue growth of +0.7%, EPS growth of +142.6%, a dividend yield of 0.0%. What stands out right now is revenue +0.7%, EPS +142.6%, free cash flow +40.7% with operating margin 9.2% and ROIC 2.0%. Valuation already assumes a fairly strong business story at P/E 41.1 and price/sales 2.7. Stock Foundry combines BIO-B price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BIO-B
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BIO-B Max Drawdown
-20.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BIO-B and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.